Guidant Shares Up on J J Deal Report  CHICAGO (Reuters) - Shares of medical device maker Guidant  Corp. &lt;A HREF="http://www.investor.reuters.com/FullQuote.aspx?ticker=GDT.N target=/stocks/quickinfo/fullquote"&gt;GDT.N&lt;/A&gt; jumped on Tuesday after a report saying the  company was in advanced talks to be acquired by health products  maker Johnson   Johnson &lt;A HREF="http://www.investor.reuters.com/FullQuote.aspx?ticker=JNJ.N target=/stocks/quickinfo/fullquote"&gt;JNJ.N&lt;/A&gt; for more than \$24 billion.